Rigel Pharmaceuticals (Nasdaq: RIGL) announced the appointment of two company veterans to leadership roles that will impact Rigel's newly refocused ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE